Hepatoprotective effect of diosmetin against thioacetamide-induced liver injury via modulating Bax/NF-κB/caspase-3/Nrf-2/PPARϒ signaling pathway in rats
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04293-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Radha Goel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Lloyd Institute of Management & Technology, Plot No.-11, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306, India. …. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Flavonoids, Protective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Thioacetamide (TAA), an established liver toxic chemical, is used to develop experimental models of liver injury by inducing inflammation, oxidative stress, and apoptosis. The current study investigates the hepatoprotective effect of diosmetin (DSM), a bioflavonoid molecule, with mechanistic investigations using an in vivo TAA-induced liver injury model because there is no precedence. In the current investigation, 30 Wistar rats were randomly assigned to five groups. The rats were given TAA (200 mg/kg) and DSM (50 and 100 mg/kg body weight) for 8 weeks. Liver function biomarkers (ALT, ASP, AST, bilirubin, GGT, CRP, albumin, globulin, and total protein) and inflammatory markers were analyzed on serum, whereas antioxidant levels, histological evaluation, and apoptotic markers were evaluated on liver tissue. The finding of this study indicated that DSM ameliorates TAA-induced increases in ALT, ASP, AST, bilirubin, GGT, CRP, MDA, albumin, globulin, total protein, and antioxidant enzyme activity such as SOD, CAT, and GSH levels. DSM reduced alterations in inflammatory biomarkers (IL-6, IL-1β, TNF-α) and apoptotic markers (Bax, NF-κB, caspase-3, Nrf-2, PPARϒ) in liver tissues. Furthermore, DSM therapy resulted in significant major changes in liver histology, fibrosis, and cell death. The current study's findings demonstrated that DSM significantly decreases hepatotoxicity by enhancing liver structure and function while suppressing oxidative stress, inflammation, and apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Lloyd Institute of Management & Technology, Plot No.-11, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306, India. radha.goel@lloydpharmacy.edu.in.
- Department of Pharmacy, Metro College of Health Sciences and Research, Plot No- 41, Knowledge Park-III, Uttar Pradesh, 201306, Noida, India.
- Department of Pharmacy, Meerut Institute of Technology, Meerut, India.
- Department of Pharmacology, Lloyd Institute of Management & Technology, Plot No.-11, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306, India.
- HR Institute of Pharmacy, HRIT University, 8th Km Stone, Delhi-Meerut Road, Ghaziabad, 201003, India.
- Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.
Zitieren
APA
Goel, R., Mishra, R., Kumar, N., Imsong, N., Singh, N., Gaur, P., Ansari, M. N., & Madkhali, H. A. (2025). Hepatoprotective effect of diosmetin against thioacetamide-induced liver injury via modulating Bax/NF-κB/caspase-3/Nrf-2/PPARϒ signaling pathway in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04293-7
Vancouver
Goel R, Mishra R, Kumar N, Imsong N, Singh N, Gaur P, et al. Hepatoprotective effect of diosmetin against thioacetamide-induced liver injury via modulating Bax/NF-κB/caspase-3/Nrf-2/PPARϒ signaling pathway in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04293-7
BibTeX
@article{Goel2025,
author = {Goel, Radha and Mishra, Rosaline and Kumar, Nitin and Imsong, Nungsangtula and Singh, Neelam and Gaur, Praveen and Ansari, Mohd Nazam and Madkhali, Hassan A},
title = {Hepatoprotective effect of diosmetin against thioacetamide-induced liver injury via modulating Bax/NF-κB/caspase-3/Nrf-2/PPARϒ signaling pathway in rats},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04293-7}
}
EUVIMED